| Catalog No. |
Size |
Price |
Figures |
|---|
Z00030-1 mg
| 1 mg | $ 630.00 |
References:
- Kim OJ, et al. Close relationship between SARS-coronavirus and group 2 coronavirus. J. Microbiol. Feb 2006; 44(1): 83-91.
- He R,et al. Analysis of multimerization of the SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. Apr 2004; 316(2): 476-483.
- Snijder EJ, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. Aug 2003; 331(5): 991-1004.
|
|---|
| Full Name | | SARS-Associated Coronavirus Spike Mosaic S (C) |
|
| Abbreviated Name-1 | SARS Coronavirus Spike mosaic S(C) |
|---|
| Description | SARS-Associated Coronavirus Spike Mosaic S (C) is an E. coli-derived recombinant. The protein contains the C-terminal t section of the Spike protein immunodominant regions. |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-HCl, 0.4% sarcosyl, 0.25% Triton X-100, 50% glycerol. |
|---|
| Stability | Five year frozen, 6 month at +4°C. |
|---|
| Specificity | Immunoreactive with sera of SARS-infected individuals. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of SARS with minimal specificity problems. |
|---|
